QRM Capital

SentiAR is a digital health software company developing a 3D augmented reality holographic platform that provides real-time visualization of a patient’s anatomy and catheter location during interventional procedures. Spun out from Washington University, it uses real-time mapping data and imaging from CT/MRI to render holographic views over the patient in the catheterization laboratory, with clinician-controlled visualization. The platform aims to improve precision and safety in procedures addressing cardiac arrhythmias. The company focuses on delivering an immersive visualization solution for interventional cardiology and related specialties.

Healium is a technology company that develops mental fitness tools and immersive, bio-data-driven experiences to support self-management of anxiety, sleep issues, burnout, and overall well-being. The platform links real-time biometric data from wearables such as heart rate and brain activity via EEG headbands to personalized video or VR assets, producing reactive media escapes controlled by the user’s physiology. By integrating wearable devices and sensors, Healium delivers data-driven content that adapts to the user in real time, aiming to reduce anxiety, improve mood, and build resilience for individuals and organizations. Peer-reviewed studies have reported rapid mood benefits and anxiety reduction in as little as four minutes.

Peptyde Bio is an Agtech startup focused on combating fungal diseases through innovative bio-fungicidal technology. The company specializes in developing natural antimicrobial peptides (AMPs) sourced from plants, which offer a cost-effective and efficient alternative for treating such diseases. By leveraging these natural compounds, Peptyde Bio aims to establish itself as a leading supplier of AMPs, providing effective solutions for agricultural challenges while promoting sustainable practices in crop protection.

Plastomics is a biotechnology company focused on chloroplast genetic engineering to enhance crop yields and nutritional quality. Its technology platform enables precise insertion of beneficial traits into chloroplasts, reducing cross-pollination and shortening breeding timelines. The company employs gene stacking and rapid breeding approaches to develop biotech crops with a broader set of traits, addressing industry challenges in seed development. Plastomics' approach is applicable across multiple crops and trait areas, supporting commercial trait expression while aiming to lower production costs. Founded in 2016 and headquartered in Saint Louis, Missouri.